#drug design — Wednesday, May 20, 2026 (1 items)
| 0 | ℹ |
Structural basis for asymmetric bis-intercalator targeting of DNA triplex junctions enabling dual inhibition of topoisomerase I and oncogene transcription.
(academic.oup.com)
|
Nucleic Acids Research 2026-05-20 | #transcription #cancer #dna #drug design #topoisomerase |